PTEN and prostate neoplasm: While they are rare in healthy prostates (~5% of epithelial cells), LSCmed cells represent up to 80% of epithelial cells in prostate tumors driven by prostate-specific deficiency of the tumor suppressor gene Pten (mice are hereafter called Pten-null) [5,7].